Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Am J Hum Genet ; 108(8): 1526-1539, 2021 08 05.
Article in English | MEDLINE | ID: mdl-34270938

ABSTRACT

Pituitary hormone deficiency occurs in ∼1:4,000 live births. Approximately 3% of the cases are due to mutations in the alpha isoform of POU1F1, a pituitary-specific transcriptional activator. We found four separate heterozygous missense variants in unrelated individuals with hypopituitarism that were predicted to affect a minor isoform, POU1F1 beta, which can act as a transcriptional repressor. These variants retain repressor activity, but they shift splicing to favor the expression of the beta isoform, resulting in dominant-negative loss of function. Using a high-throughput splicing reporter assay, we tested 1,070 single-nucleotide variants in POU1F1. We identified 96 splice-disruptive variants, including 14 synonymous variants. In separate cohorts, we found two additional synonymous variants nominated by this screen that co-segregate with hypopituitarism. This study underlines the importance of evaluating the impact of variants on splicing and provides a catalog for interpretation of variants of unknown significance in POU1F1.


Subject(s)
High-Throughput Screening Assays/methods , Hypopituitarism/pathology , Mutation , Pituitary Hormones/deficiency , RNA Splicing/genetics , Transcription Factor Pit-1/genetics , Adolescent , Adult , Child , Child, Preschool , Humans , Hypopituitarism/etiology , Hypopituitarism/metabolism , Male , Pedigree
2.
Pediatr Cardiol ; 39(8): 1707-1716, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30242442

ABSTRACT

Amiodarone-induced hyperthyroidism is a known side effect of amiodarone treatment. In the pediatric population, long-term amiodarone treatment is rarely indicated because of its severe side effects including thyroid function impairment. Treatment is therefore restricted to therapy-resistant arrhythmias. In the literature, scarce data are available on the management and therapy of amiodarone-induced thyroid dysfunction at a young age. We present three adolescent patients developing amiodarone-induced thyrotoxicosis in the months after amiodarone therapy. A latency period for thyroid dysfunction has been described in adulthood but was not previously reported in pediatric patients. The gap between amiodarone treatment and the development of symptoms and the diagnosis of hyperthyroidism was between 3 and 10 months. In two patients, hyperthyroidism was transient and resolved without treatment. These two patients, one boy and on girl, were almost asymptomatic. In contrast, in one male patient overt and severe hyperthyroidism developed. We began treatment with thiamazole without benefit. Control of hyperthyroidism was achieved under prednisone treatment, which was continued for 9 months. Clinical evaluation proved an amiodarone-induced destructive thyroiditis in this patient. Amiodarone-induced thyroid dysfunction is frequent also in pediatric patients with long-term amiodarone treatment. Patients and clinicians should be aware of the impact of amiodarone on thyroid function during and also in the months and maybe years after treatment. Careful follow-up is needed, as symptoms might be associated with the underlying cardiac disease in these patients. Amiodarone-induced thyrotoxicosis often resolves without treatment but can be challenging in some cases.


Subject(s)
Amiodarone/adverse effects , Anti-Arrhythmia Agents/adverse effects , Hyperthyroidism/chemically induced , Adolescent , Amiodarone/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Antithyroid Agents/therapeutic use , Arrhythmias, Cardiac/drug therapy , Female , Glucocorticoids/therapeutic use , Humans , Hyperthyroidism/drug therapy , Male , Methimazole/therapeutic use , Prednisolone/therapeutic use , Thyroid Function Tests/methods , Thyroid Gland/drug effects , Thyroid Gland/pathology
3.
J Clin Res Pediatr Endocrinol ; 9(4): 360-365, 2017 12 15.
Article in English | MEDLINE | ID: mdl-28515031

ABSTRACT

Acrodysostosis is a very rare congenital multisystem condition characterized by skeletal dysplasia with severe brachydactyly, midfacial hypoplasia, and short stature, varying degrees of intellectual disability, and possible resistance to multiple G protein-coupled receptor signalling hormones. Two distinct subtypes are differentiated: acrodysostosis type 1 resulting from defects in protein kinase type 1-α regulatory subunit and acrodysostosis type 2 caused by mutations in phosphodiesterase 4D (PDE4D). Most cases are sporadic. We report on a rare multigenerational familial case of acrodysostosis type 2 due to a novel autosomal dominantly inherited PDE4D mutation. A 3.5-year-old boy presented with short stature, midfacial hypoplasia, severe brachydactyly, developmental delay, and behavioural problems. Laboratory investigations revealed mild thyrotropin resistance. His mother shared some characteristic features, such as midfacial hypoplasia and severe brachydactyly, but did not show short stature, intellectual disability or hormonal resistance. Genetic analysis identified the identical, novel heterozygous missense mutation of the PDE4D gene c.569C>T (p.Ser190Phe) in both patients. This case illustrates the significant phenotypic variability of acrodysostosis even within one family with identical mutations. Hence, a specific clinical diagnosis of acrodysostosis remains challenging because of great interindividual variability and a substantial overlap of the two subtypes as well as with other related Gsα-cAMP-signalling-linked disorders.


Subject(s)
Cyclic Nucleotide Phosphodiesterases, Type 4/genetics , Dysostoses/genetics , Intellectual Disability/genetics , Mutation, Missense , Osteochondrodysplasias/genetics , Adult , Amino Acid Substitution , Child, Preschool , Cyclic AMP-Dependent Protein Kinases/metabolism , Cyclic Nucleotide Phosphodiesterases, Type 4/metabolism , Female , Humans , Male , Mothers , Nuclear Family , Phenotype , Phosphorylation , Serine/genetics
8.
J Pediatr Endocrinol Metab ; 27(11-12): 1043-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25367688

ABSTRACT

BACKGROUND: Cushing's disease is very rare in children, and the diagnosis is frequently delayed by several years. OBJECTIVE: We report a case of prepubertal Cushing's disease with a medical history of only 9 months. This case illustrates the difficulties involved in diagnosing children at the early stage of the disease. CASE PRESENTATION: An 8-year-old prepubertal boy presented with rapid weight gain accompanied by a decreasing growth velocity and hirsutism. Thyroid function tests and growth factor levels were normal, thus excluding hypothyroidism and growth hormone deficiency. Cushing's syndrome was confirmed by elevated 24-h urinary free cortisol levels, increased diurnal cortisol levels, and a lack of cortisol suppression in the low-dose dexamethasone suppression test. Further tests to investigate the source of the hypercortisolism showed the following results: Basal morning adrenocorticotropic hormone (ACTH) was normal. The high-dose dexamethasone suppression test led to a 51% decrease in cortisol level. In the corticotropin-releasing hormone (CRH) test, ACTH and cortisol increased only by 28%. Repeated magnetic resonance imaging (MRI) finally revealed a microadenoma in the anterior pituitary, thus establishng the diagnosis of Cushing's disease. Upon diagnosis, the patient underwent transsphenoidal surgery. Histological analysis confirmed an ACTH-secreting pituitary adenoma. CONCLUSION: This case illustrates the difficulties associated with the clinical, biochemical, and radiological diagnoses of Cushing's disease in children. Early diagnosis remains a challenge because test results often do not match standard diagnostic criteria.


Subject(s)
ACTH-Secreting Pituitary Adenoma/diagnosis , Adenoma/diagnosis , Cushing Syndrome/diagnosis , ACTH-Secreting Pituitary Adenoma/blood , ACTH-Secreting Pituitary Adenoma/surgery , Adenoma/blood , Adenoma/surgery , Adrenocorticotropic Hormone/blood , Child , Corticotropin-Releasing Hormone/blood , Cushing Syndrome/blood , Cushing Syndrome/surgery , Early Diagnosis , Humans , Hydrocortisone/blood , Magnetic Resonance Imaging , Male , Puberty
9.
GMS Z Med Ausbild ; 29(1): Doc07, 2012.
Article in English, German | MEDLINE | ID: mdl-22403592

ABSTRACT

OBJECTIVE: Procedural skills education has a high priority for medical students. However, it is not clear what kind of skills they consider important and whether their perception differs from the physicians' view. METHODS: We conducted a survey on 26 skills in internal medicine among medical students and physicians. Ninety-five fourth year and 62 final year students along with 67 physicians working in medical departments participated in the survey. A similar but smaller survey was completed earlier before the implementation of a skills training at the faculty. RESULTS: Students generally preferred technically complex skills while, in contrast, physicians found "bed-side-skills" more important. The result was independent of the students' participation in the skills training or of the physicians' experience. A similar result was achieved in the smaller survey before the implementation of the skills training. CONCLUSION: Students and physicians significantly differ in their entitlement towards procedural skills education. This should be considered when educational strategies are being discussed.


Subject(s)
Attitude of Health Personnel , Clinical Competence , Computer Simulation , Faculty, Medical , Internal Medicine/education , Manikins , Students, Medical , Curriculum , Data Collection , Germany , Humans , Needs Assessment
SELECTION OF CITATIONS
SEARCH DETAIL
...